Auteurs

David Mulder

Collaborateur senior

Read More

Christian Dekoninck

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Dr Paul England

Senior professional support lawyer

Read More
Auteurs

David Mulder

Collaborateur senior

Read More

Christian Dekoninck

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Dr Paul England

Senior professional support lawyer

Read More

9 novembre 2020

Pharmaceutical patent law – 1 de 2 Publications

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here

Dans cette série

Brevets et innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

Quick read

par plusieurs auteurs

Brevets et innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

Quick read

par plusieurs auteurs

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

UPC

It is time to think about UPC opt-out again: how it is achieved and its strategic implications

Part 2

17 janvier 2022
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus
UPC

It is time to think about UPC opt-out again: what opt-out does

Part 1

17 janvier 2022
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus
Brevets et innovation

Taylor Wessing announces a major Unified Patent Court publishing project

22 novembre 2021
Quick read

par plusieurs auteurs

Cliquer ici pour en savoir plus